ArticleFrontiers in neurology2025
An interpretable machine learning approach for predicting drug-resistant epilepsy in children with tuberous sclerosis complex.
Article in Frontiers in neurology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: This study developed and validated an interpretable machine learning (ML) algorithm for predicting the risk of drug-resistant epilepsy (DRE) in children with Tuberous sclerosis (TSC). Methods: To estimate the risk of DRE in pediatric TSC patients, an interpretable ML model was developed and validated. Clinical data were retrospectively collected from 88 pediatric patients with TSC-related epilepsy. 9 ML algorithms were applied, such as random forest (RF), to construct predictive models. To improve interpretability, SHapley Additive exPlanations (SHAP) were employed, providing both global and individualized feature importance explanations. Results: The RF model outperformed all other algorithms, yielding an AUC of 0.862 and a specificity of 0.930. Key predictors of DRE included a history of infantile epileptic spasms syndrome (IESS), multifocal discharges on EEG, three or more cortical tubers, and the use of three or more antiseizure medications (ASMs). The model was further evaluated using tenfold cross-validation and showed good calibration and clinical utility, as confirmed by decision curve analysis (DCA). Conclusion: The RF-based prediction model provides a valuable tool for early identification of children with TSC at high risk for DRE, supporting individualized treatment decisions. The integration of SHAP improves model transparency and enhances clinical interpretability.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.